Hypospadias and maternal exposures to cigarette smoke

Paediatric and Perinatal Epidemiology

Volumn 19, Issue 6, 2005, Pages 406-412

  Carmichael, Suzan L ^a,d   Shaw, Gary M ^a   Laurent, Cecile ^a   Lammer, Edward J ^b   Olney, Richard S ^c  

^a March of Dimes Birth Defects Foundation   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d California Birth Defects Monitoring Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOBACCO SMOKE;

ADULT; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HOME; HOUSEHOLD; HUMAN; HYPOSPADIAS; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT MALFORMATION; MAXIMUM LIKELIHOOD METHOD; NEWBORN; PASSIVE SMOKING; POPULATION RESEARCH; PREGNANCY; RISK; RISK ASSESSMENT; SCHOOL; WORK;

ADULT; FEMALE; HUMANS; HYPOSPADIAS; MALE; MATERNAL EXPOSURE; ODDS RATIO; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION; UNITED STATES;

EID: 28044457199     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/j.1365-3016.2005.00680.x     Document Type: Article

References (37)

1. Moller JH, Weidner IS. Epidemiology of cryptorchidism and hypospadias. Epidemiology 1999; 10:352-354.
2. Carmichael SL, Shaw GM, Nelson V, Selvin S, Torfs CP, Curry CJ. Hypospadias: trends and descriptive epidemiology in a California population. Epidemiology 2003; 14:701-706.
3. Akre O, Lipworth L, Cnattingius S, Sparén P, Ekbom A. Risk factor patterns for cryptorchidism and hypospadias. Epidemiology 1999; 10:364-369.
4. Weidner IS, Moller H, Jensen TK, Skakkebaek NE. Risk factors for cryptorchidism and hypospadias. Journal of Urology 1999; 161:1606-1609.
5. Czeizel A, Toth J. Correlation between the birth prevalence of isolated hypospadias and parental subfertility. Teratology 1990; 41:167-172.
6. Xiong X, Wang FL, Davidge ST, Demianczuk NN, Mayes DC, Olson DM, et al. Maternal smoking and preeclampsia. Journal of Reproductive Medicine 2000; 45:727-732.
7. Lindqvist PG, Marsal K. Moderate smoking during pregnancy is associated with a reduced risk of preeclampsia. Acta Obstetricia et Gynecologica Scandinavica 1999; 78:693-697.
8. Michnovicz JJ, Naganuma H, Hershcopf RJ, Bradlow HL, Fishman J. Increased urinary catechol estrogen excretion in female smokers. Steroids 1988; 52:69-83.
9. Sharpe R, Skakkebaek N. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993; 341:1392-1395.
10. Kallen K. Role of maternal smoking and maternal reproductive history in the etiology of hypospadias in the offspring. Teratology 2002; 66:185-191.
11. Kallen B. Case-control study of hypospadias, based on registry information. Teratology 1988; 38:45-50.
12. Kallen B, Winberg J. An epidemiologic study of hypospadias in Sweden. Acta Pediatrica Scandinavica 1982; 23:1-21.
13. Van Den Eeden SK, Karagas MR, Daling JR, Vaughan TL. A case-control study of maternal smoking and congenital malformations. Paediatric and Perinatal Epidemiology 1990; 4:147-155.
14. Seidman DS, Ever-Hadani P, Gale R. Effect of maternal smoking and age on congenital anomalies. Obstetrics and Gynecology 1990; 76:1046-1050.
15. Shiono PH, Klebanoff MA, Berendes HW. Congenital malformations and maternal smoking during pregnancy. Teratology 1986; 112:684-695.
16. Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, et al. The National Birth Defect Prevention Study. Public Health Reports 2001; 116 (Suppl. 2):32-40.
17. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA, National Birth Defects Prevention Study. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Research Part A: Clinical and Molecular Teratology 2003; 67:193-201.
18. Selvin S. Measures of Risk: Rates and Probabilities. Statistical Analysis of Epidemiologic Data. New York: Oxford University Press, 1991; pp. 1-35.
19. Selvin S. Practical Biostatistical Methods. Belmont, CA: Wadsworth Publishing Company, 1995.
20. Van Der Werff JFA, Nievelstein RAJ, Brands E, Luijsterburg AJM, Vermeij-Keers C. Normal development of the male anterior urethra. Teratology 2000; 61:172-183.
21. Carmichael SL, Ahluwalia IB, The PRAMS Working Group. Correlates of postpartum smoking relapse: results from the Pregnancy Risk Assessment Monitoring System (PRAMS). American Journal of Preventive Medicine 2000; 19:193-196.
22. Ventura SJ, Hamilton BE, Mathews TJ, Chandra A. Trends and variations in smoking during pregnancy and low birth weight: evidence from the birth certificate, 1990-2000. Pediatrics 2003; 111:1176-1180.
23. Colman GJ, Joyce T. Trends in smoking before, during, and after pregnancy in ten states. American Journal of Preventive Medicine 2003; 24:29-35.
24. English PB, Eskenazi B, Christianson RE. Black-white differences in serum cotinine levels among pregnant women and subsequent effects on infant birthweight. American Journal of Public Health 1994; 84:1439-1443.
25. Klebanoff M, Levine R, Clemens J, DerSimonian R, Wilkins D. Serum cotinine concentration and self-reported smoking during pregnancy. American Journal of Epidemiology 1998; 148:259-262.
26. Verkerk PH, Buitendijk SE, Verloove-Vanhorick SP. Differential misclassification of alcohol and cigarette consumption by pregnancy outcome. International Journal of Epidemiology 1994; 23:1218-1225.
27. Lippman A, Mackenzie SG. What is 'recall bias' and does it exist? In: Prevention of Physical and Mental Congenital Defects. Editor: Marois M. New York, NY: Alan R. Liss, Inc. 1985; pp. 205-209.
28. Swan SH, Shaw GM, Shulman J. Reporting and selection bias in case-control studies of congenital malformations. Epidemiology 1992; 3:356-363.
29. Khoury MJ, James LM, Erickson JD. On the use of affected controls to address recall bias in case-control studies of birth defects. Teratology 1994; 49:273-281.
30. Klemetti A, Saxen L. Prospective versus retrospective approach in the search for environmental causes of malformations. American Journal of Public Health 1967; 57:2071-2075.
31. Werler MM, Pober BR, Nelson K, Holmes LB. Reporting accuracy among mothers of malformed and nonmalformed infants. American Journal of Epidemiology 1989; 129:415-421.
32. Kizilcan F, Tanyel FC, Cakar N, Büyükpamukca N, Hicsönmez A. The effect of intrauterine vascular compromise on further development of corpus spongiosum and urethra. European Journal of Pediatric Surgery 1994; 4:26-29.
33. Abuelo DN, Forman EN, Rubin LP. Limb defects and congenital anomalies of the genitalia in an infant with homozygous a-Thalassemia. American Journal of Medical Genetics 1997; 68:158-161.
34. Gray LE Jr, Ostby JFJ, Price M, Veeramachaneni DNR, Parks L. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicological Science 2000; 58:350-365.
35. Guo YL, Lambert GH, Hsu C-C. Growth abnormalities in the population exposed in utero and early postnatally to polychlorinated biphenyls and dibenzofurans. Environmental Health Perspectives 1995; 103 (Suppl. 6):117-122.
36. Baskin LS. Hypospadias and urethral development. Journal of Urology 2000; 163:951-956.
37. Baskin LS, Erol A, Li YW, Cunha GR. Anatomical studies of hypospadias. Journal of Urology 1998; 160:1108-1115.